Clinical Trials Logo
  1. Home
  2. PRP
  3. NCT04976361

Macular Vessels Density Before and After PRP in Patients With Proliferative Diabetic Retinopathy

PRP Clinical Trial

Official title:
Macular Vessels Density Before and After Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy

Clinical Trial Summary

In this study, OCTA is used to study the vascular changes following PRP in patients with PDR; regarding vessels density at 1 month and 6 months follow up period and measure superficial, deep, and outer retina for fovea, para-fovea and whole image.

Clinical Trial Description

The global prevalence of diabetes mellitus in 2019 is estimated to be 9.3% (463 million people).1 Diabetic retinopathy (DR) is microangiopathy characterized by capillary non- perfusion, microaneurysms (MAs), and retinal ischemia. 2It may cause many complications, such as diabetic macular edema (DME) and diabetic macular ischemia (DMI).3 Capillary ischemia decreases the nutrition of the retina and causes hypoxia which results in increased level of vascular endothelial growth factor (VEGF), which promotes angiogenic responses causing both neovascularization (proliferative diabetic retinopathy, PDR) and vascular permeability (macular edema). Panretinal photocoagulation (PRP) by argon or diode laser is the standard treatment for proliferative diabetic retinopathy. It improves oxygenation to the ischemic retina. Destruction of the highly active photoreceptor cells is the suggested mechanism of action for PRP. Subsequently, production of vascular endothelial growth factor (VEGF), the key player in neovascularization process, is reduced leading to regression of new vessels.5 PDR eyes have an overall lower blood flow than normal or non-PDR eyes, parallel to the higher level of retinal ischemia and disease severity. With regression of these neovascular and shunt vessels following PRP, normalization of flow in the macula may reverse the ischemia and decrease the stimulus for new blood vessel formation. Closure of intraretinal microvascular abnormalities and neovascularization would theoretically increase overall resistance to flow and, combined with the constriction of the large vessel in response to increased oxygen in the inner retina, collectively decrease the overall blood flow.6 While most previous studies have explored the large vessel effects of PRP, the development of ocular coherence tomography angiography (OCTA) allowed the study of microvascular retinal changes in a detailed manner. It is a non-invasive modality that allows vascular mapping with high speed and quality and promotes visualization of vascular system in different retinal and choroidal levels. Several investigations have demonstrated the competence of OCTA in the quantification of microvascular density, choroidal flow area, and foveal avascular zone (FAZ) area in diabetic patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04976361
Study type Interventional
Source Minia University
Contact
Status Completed
Phase N/A
Start date March 1, 2019
Completion date May 1, 2021
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05160441 - Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis Phase 3
Enrolling by invitation NCT05944757 - Compare of PRP Autologous Serum and Autologous Serum by Intrastromal Injection in Different Eye Disease Conditions N/A
Not yet recruiting NCT03633266 - Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy N/A
Recruiting NCT03830775 - A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries N/A
Recruiting NCT04811287 - PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome N/A
Recruiting NCT04586361 - Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear Phase 4
Completed NCT05827484 - The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries Phase 4
Recruiting NCT04765930 - Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma N/A
Terminated NCT03937765 - The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites N/A
Recruiting NCT05241964 - Platelet-rich Plasma(PRP) Injection in ED N/A
Recruiting NCT05279560 - Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation N/A
Not yet recruiting NCT06298110 - The Effect of PRP on Wound Healing in High Risk Patients Undergoing Abdominal Hysterectomy Phase 2/Phase 3
Recruiting NCT06028009 - PRP Injections for Genitourinary Syndrome of Menopause N/A
Recruiting NCT05412381 - PRP in ACLR to Prevent PTOA Phase 4
Active, not recruiting NCT04556825 - Arthroscopic Treatment Combined With PRP Injection for Refractory Elbow Epicondylitis N/A
Recruiting NCT03987256 - ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation N/A
Completed NCT04320498 - Short Term Results of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure Phase 4
Completed NCT04640662 - The Effects of Platelet-Rich Plasma Versus Prolotherapy On Rotator Cuff Tendinopathy: A Randomized Controlled Trial. Phase 1
Completed NCT03371888 - The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders Phase 2/Phase 3
Recruiting NCT04519047 - IA Injection of Rejoint Gel and PRP in Patients With Unilateral Knee OA Phase 1